Primary Peritoneal Cavity Cancer clinical trials at University of California Health

1 research study open to eligible people

XMT-1660 in Participants With Solid Tumors
open to eligible people ages 18 years and up
A Study of XMT-1660 in Solid Tumors
at UC Irvine

Our lead scientists for Primary Peritoneal Cavity Cancer research studies include Ritesh Parajuli.

Last updated: September 20, 2023

XMT-1660 in Participants With Solid Tumors